Concentric Capital Strategies’s Johnson & Johnson JNJ Stock Holding History

Concentric Capital Strategies’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	42,565 +34,377	+420%	+$8.01M	0.6%	16
2026 Q1	$2M	Sell	8,188 -20,047	-71%	-$4.67M	0.17%	98
2025 Q4	$5.84M	Buy	28,235 +25,267	+851%	+$5M	0.28%	90
2025 Q3	$550K	Buy	2,968 +113	+4%	+$19.4K	0.02%	251
2025 Q2	$436K	Buy	+2,855	New	+$439K	0.02%	251
2025 Q1	–	Sell	-2,720	Closed	-$393K	–	230
2024 Q4	$393K	Sell	2,720 -7,338	-73%	-$1.14M	0.02%	232
2024 Q3	$1.63M	Buy	10,058 +4,016	+66%	+$640K	0.07%	219
2024 Q2	$883K	Buy	+6,042	New	+$899K	0.04%	256
2023 Q4	–	Sell	-3,268	Closed	-$509K	–	272
2023 Q3	$509K	Buy	+3,268	New	+$539K	0.05%	160

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Concentric Capital Strategies's JNJ Position: Q2 2026 in Review

Concentric Capital Strategies increased its Johnson & Johnson (JNJ) stake by 420% in Q2 2026, buying an estimated $8.01M and bringing the position to 42,565 shares worth $10.8M. The position accounts for 0.6% of the portfolio, ranked #16.

Concentric Capital Strategies first reported a position in JNJ in Q3 2023 and has held it in 9 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Concentric Capital Strategies held 42,565 shares of Johnson & Johnson worth $10.8M as of Q2 2026.
Concentric Capital Strategies bought 34,377 Johnson & Johnson shares in Q2 2026, an estimated $8.01M.
Johnson & Johnson made up 0.6% of Concentric Capital Strategies's portfolio in Q2 2026, its #16 holding.
Concentric Capital Strategies first reported a position in Johnson & Johnson in Q3 2023 and has held it in 9 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.